A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)
Clinical trial NCT00501046 · COMPLETED
Trial details
- NCT number
- NCT00501046
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2011-10-01
- Enrollment
- 1015
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.